drugset / Trial / NCT01238796

A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin

NCT01238796

Phase 1 Completed 45 enrolled Cumberland Pharmaceuticals
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the effect of renal function on the biological activity of telavancin using blood samples obtained from subjects with normal renal function, severe renal impairment, and end stage renal disease.

Timeline

Start
2010-12
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Telavancin Other / unclassified Intravenous